Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Setoain

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|July 11, 2018
Unilateral pallidal stimulation for disabling dystonia due to Rasmussen's diseaseMar Carreño, Maria José Martí, Ibán Aldecoa, et al.
Neuroimage|January 22, 2026
Added Value of Quantitative [<sup>18</sup>F]FDG-PET Analysis in MRI-negative Epilepsy: A simulation-based study using realistic ground-truthsAndrés Perissinotti, Arnau Farré-Melero, Francisco J López-González, et al.
Cerebral Cortex (New York, N.Y. : 1991)|October 23, 2024
Subject-based assessment of large-scale integration dynamics in epileptic brain networks: insights from the intrinsic ignition frameworkAntonio Donaire, Nelly Padilla, Anira Escrichs, et al.
Frontiers in Oncology|July 22, 2022
Long-Term Responders After Autologous Stem Cell Transplantation in Multiple MyelomaAina Oliver-Caldes, Juan Carlos Soler-Perromat, Ester Lozano, et al.
Hematological Oncology|November 9, 2023
A low total metabolic tumor volume independently predicts for a longer time to first treatment in initially observed, low tumor burden follicular lymphomaPablo Mozas, Sebastian Casanueva-Eliceiry, Andrea Rivero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2020
Mutational Landscape and Tumor Burden Assessed by Cell-free DNA in Diffuse Large B-Cell Lymphoma in a Population-Based StudyAlfredo Rivas-Delgado, Ferran Nadeu, Anna Enjuanes, et al.
Epilepsy Research|January 3, 2017
Epilepsy surgery in drug resistant temporal lobe epilepsy associated with neuronal antibodiesMar Carreño, Christian G Bien, Ali A Asadi-Pooya, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2022
Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II TrialEva Giné, Fátima de la Cruz, Ana Jiménez Ubieto, et al.
American Journal of Hematology|March 7, 2022
Results of ARI-0001 CART19 cell therapy in patients with relapsed/refractory CD19-positive acute lymphoblastic leukemia with isolated extramedullary diseaseValentín Ortiz-Maldonado, Anna Alonso-Saladrigues, Marta Español-Rego, et al.
Blood Advances|November 27, 2024
Clinical impact of [18F]FDG-PET/CT in ARI0002h treatment, a CAR-T against BCMA for relapsed/refractory multiple myelomaInés Zugasti, Marta Tormo-Ratera, Aina Oliver-Caldés, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Journal of Neurology, Neurosurgery, and Psychiatry|July 11, 2018
Unilateral pallidal stimulation for disabling dystonia due to Rasmussen's diseaseMar Carreño, Maria José Martí, Ibán Aldecoa, et al.
Neuroimage|January 22, 2026
Added Value of Quantitative [<sup>18</sup>F]FDG-PET Analysis in MRI-negative Epilepsy: A simulation-based study using realistic ground-truthsAndrés Perissinotti, Arnau Farré-Melero, Francisco J López-González, et al.
Cerebral Cortex (New York, N.Y. : 1991)|October 23, 2024
Subject-based assessment of large-scale integration dynamics in epileptic brain networks: insights from the intrinsic ignition frameworkAntonio Donaire, Nelly Padilla, Anira Escrichs, et al.
Frontiers in Oncology|July 22, 2022
Long-Term Responders After Autologous Stem Cell Transplantation in Multiple MyelomaAina Oliver-Caldes, Juan Carlos Soler-Perromat, Ester Lozano, et al.
Hematological Oncology|November 9, 2023
A low total metabolic tumor volume independently predicts for a longer time to first treatment in initially observed, low tumor burden follicular lymphomaPablo Mozas, Sebastian Casanueva-Eliceiry, Andrea Rivero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2020
Mutational Landscape and Tumor Burden Assessed by Cell-free DNA in Diffuse Large B-Cell Lymphoma in a Population-Based StudyAlfredo Rivas-Delgado, Ferran Nadeu, Anna Enjuanes, et al.
Epilepsy Research|January 3, 2017
Epilepsy surgery in drug resistant temporal lobe epilepsy associated with neuronal antibodiesMar Carreño, Christian G Bien, Ali A Asadi-Pooya, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2022
Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II TrialEva Giné, Fátima de la Cruz, Ana Jiménez Ubieto, et al.
American Journal of Hematology|March 7, 2022
Results of ARI-0001 CART19 cell therapy in patients with relapsed/refractory CD19-positive acute lymphoblastic leukemia with isolated extramedullary diseaseValentín Ortiz-Maldonado, Anna Alonso-Saladrigues, Marta Español-Rego, et al.
Blood Advances|November 27, 2024
Clinical impact of [18F]FDG-PET/CT in ARI0002h treatment, a CAR-T against BCMA for relapsed/refractory multiple myelomaInés Zugasti, Marta Tormo-Ratera, Aina Oliver-Caldés, et al.
Pageof 7